1,556 followers
Therapeutic targeting of TWEAK/Fnl4 in cancer: exploiting the intrinsic tumor cell killing capacity of the pathway. https://t.co/npGqpGRNZB
Death Receptors and Cognate Ligands in Cancer
Overview of attention for book
Table of Contents
-
Altmetric BadgeBook Overview
-
Altmetric BadgeChapter 17 Targeting Death-Receptors in Radiation Therapy
-
Altmetric BadgeChapter 18 Ubiquitination and TNFR1 signaling.
-
Altmetric BadgeChapter 18 Therapeutic Targeting of TWEAK/Fn14 in Cancer: Exploiting the Intrinsic Tumor Cell Killing Capacity of the Pathway
-
Altmetric BadgeChapter 19 APRIL in B-cell Malignancies and Autoimmunity
-
Altmetric BadgeChapter 20 Glucocorticoid-Mediated Apoptosis Resistance of Solid Tumors
-
Altmetric BadgeChapter 21 FasL Expression and Reverse Signalling
-
Altmetric BadgeChapter 22 Death Ligands Designed to Kill: Development and Application of Targeted Cancer Therapeutics Based on Proapoptotic TNF Family Ligands
-
Altmetric BadgeChapter 23 Impact of TNF-R1 and CD95 Internalization on Apoptotic and Antiapoptotic Signaling
-
Altmetric BadgeChapter 24 Many Checkpoints on the Road to Cell Death:Regulation of Fas–FasL Interactions and Fas Signaling in Peripheral Immune Responses
-
Altmetric BadgeChapter 25 Autophagy in Cancer and Chemotherapy
-
Altmetric BadgeChapter 26 The role of TNF in cancer.
-
Altmetric BadgeChapter 27 From Biochemical Principles of Apoptosis Induction by TRAIL to Application in Tumour Therapy
Attention for Chapter 18:
Therapeutic Targeting of TWEAK/Fn14 in Cancer: Exploiting the Intrinsic Tumor Cell Killing Capacity of the Pathway